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some of the TcR genes. Approximately 95 per cent
of circulating T cells undergo the entire spectrum of
rearrangements and are á/â positive but a small
population of ã/ä T-cells does not undergo â/á
rearrangements.

T-Cell Receptor (TcR) Gene Rearrangement
Studies: A Useful Adjunct for the Diagnosis
of T-Cell Lymphoproliferative Disorders
Dr Shahid Pervez, Histopathology
Dr Tariq Moatter, Molecular Pathology
Background
The molecular diagnosis of lymphoproliferative
disorders is based on the assumption that the cells
of a malignancy have a clonal origin reflected by
the presence of clonally rearranged
immunoglobulin (Ig) and T-cell receptor (TcR)
genes1.
T-lymphocytes rearrange their TcR genes to
encode a unique antigen receptor expressed on
the surface of T cells (Fig 1). TcR is composed of á,
â, ã and ä chain genes, which rearrange in the
germline genome to give a functional T-cell
receptor. Rearrangements involve random
assembly of different variable (v), sometimes
diversity (D) and joining (J) gene segments (Fig 2).

Figure 1:
Germline organisation of T-cell Receptor (TcR) genes

In diagnostic pathology it is relatively easy to
determine clonality of B-lymphoproliferative
disorders by immunohistochemical techniques for
instance by using monoclonal antibodies to kappa
and lambda light chains to look for light chain
restriction. However in contrast by routine
immunohistochemistry it is difficult to establish
clonality (monoclonality) or otherwise of a
T lymphoproliferative disorder. The whole idea of Tcell receptor gene rearrangement is based on the
assumption that in T-cell Non-Hodgkin's lymphoma
(T-NHL) all tumor cells are the progeny of a single
transformed T-cell that is, they are monoclonal.
Therefore it will be right to believe that all these
neoplastic T- cells arrange gene in an identical
fashion and therefore come to the detection levels
as a single band by PCR (Fig. 3 and 4). In contrast
a reactive or in other words polyclonal population
will have a heterogenous population of T-cells
arranging TcR genes in variable manner and
therefore appearing as smear on PCR based gel
2
analysis (Fig. 3 and 4).
T-Cell Receptor Gene Arrangements
TcR genes undergo VDJ or VJ rearrangements in
the sequential orders of TcRä, TcRã, TcRâ and
TcRá. All T-cells undergo rearrangement of at least

Figure 2:
Schematic illustration of Ig and TcR gene rearrangement
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Molecular analysis of the TcRâ and TcRã genes is
commonly used to distinguish monoclonal T-cell
neoplasms from polyclonal reactive process. The
reason that TcRä gene is not commonly targeted is
because it is deleted during TcRá gene
rearrangement. TcRá gene is not targeted because
it has so many possible rearrangements that
current probe technology cannot handle the
diversity.

Lineage Infidelity
A monoclonal TcR gene rearrangement does not
always translate into T-cell lineage as many
precursor B cell lymphoblastic leukemias and
lymphomas are positive for such rearrangements
and vice versa. A mature T-cell lymphoma known to
show this phenomenon is AILT type T NHL5.
Clinical Utility
T-cell receptor gene rearrangement studies are
used to distinguish benign from malignant Tlymphoid proliferations. Benign reactive T
lymphoid proliferations do not harbour monoclonal
rearrangements in control to malignant lymphoid
tumors. However in spite of its incredible power,
results of clonality assays should be interpreted
with caution. It is important to recognize that
clonality is not always synonymous with
malignancy. Therefore, all results must be
interpreted with morphological and
immunohistochemical clinical data6.

Most TcR gene analysis nowadays are PCRbased. Because of the complexity of TcRâ locus
PCR for these rearrangements require a large
number of primers and thus may not be the
preferred locus for PCR testing in clinical
diagnostic scenario. Nonetheless commercially
available standardised Biomed primers for TcRâ
3
appear to work well in practice .
The rearranged TcRã is ideal for PCR amplification
for two reasons. First because TcRã locus is
consistently rearranged prior to TcRâ locus.
Second, nearly all T-cells harbour rearrangements
involving one of eleven variable segments. Eight of
these segments are homologous to one another
and can thus be targeted by a single consensus
primer. In the event that one of the remaining
variable segments was used, additional primers
are employed in a multiplex fashion, along with
several joining region primers to detect virtually all
possible TcRã gene rearrangements. Since this is
a PCR based test directed against genomic DNA,
TcR PCR can be performed on paraffin embedded
tissue.

The test can also be utilised for differentiating T and
B cell lineage of a lymphoid proliferation. A
complicating factor is lineage infidelity in a minority
of cases.
Overall, it has been shown that when diagnostic
uncertainty remains after morphologic and
immunophenotypic examination, gene
rearrangement studies are helpful in 72 per cent of
the cases. However, if molecular results appear to
be in violation with morphologic diagnosis, timetested morphologic impression or diagnosis should
prevail over molecular results.

False Positive and Negative Results
PCR based TcRã analysis using standardised
biomed primers result in very few false negative
results provided the sample is representative.
Excluding a problem with contamination false
positive results are most common when only few
lymphoid cells are present in the sample as
selective amplification of these few cells may result
in an apparent positive result (pseudoclonality).
Testing small samples in duplicate will identify
these potential false positive cases and will result
in an oligoclonal pattern of amplification ie,
different sized gene rearrangements on different
runs. This should not be interpreted as evidence of
a monoclonal population4.
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Figure 3:
Ethidium bromide-stained 2% agarose gel showing 240
bp -globin product of different T-NHL samples. M represents
the molecular weight marker along with negative (-C) and
positive (+C) controls
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Test Samples

Negative Control

TcR â, sample showing clonal (single) peak
TcR â tube A, negative control
Figure 4:
Heteroduplex analysis of 6% ethidium bromide-stained
polyacrylamide gel illustrates rearranged TcR PCR products
for T-malignancy cases, followed with genescan of 2 samples
showing clonal and polyclonal peaks with controls
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TcR â, sample polyclonal (several) peaks
Positive Control

TcR â tube A, positive clonal control showing
clonal (single) peak

TcR â tube A, positive polyclonal clonal control
showing polyclonal (several) peaks
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Vitamin D Measurement
Dr Aysha Habib Khan, Chemical Pathology

QUIZ
Dr Naveen Naz Syed, Haematology

The measurement of vitamin D is becoming
increasingly important in the management of
patients with various disorders of calcium
metabolism associated with rickets,
osteomalacia, neonatal hypocalcaemia,
pregnancy, nutritional and renal osteodystrophy,
hypo and hyperparathyroidism as well as
osteoporosis.

82-year old male presented with history of
progressive fatigue and shortness of breath on
exertion since three months. Physical exam
showed pallor with mild scleral icterus, and
palpable liver 2 cm below the left costal margin.
Complete blood count revealed Hemoglobin
2.7g/dl, hematocrit 7.7 per cent, MCV 129 fl, MCH
34.8 pg, white blood cell count 2600/cmm and
platelets 20,000/cmm.

As calciferol from the skin enters the circulation, it
is metabolised to several forms, the major form
being 25-hydroxycalciferol (25-OHD) in the liver.
Only a small amount is metabolised in the kidney to
other dihydroxy vitamin D metabolites in man.
Since 25-OH D is the predominant circulating form
in the normal population, it is the most reliable
index of vitamin D status.

A

Factors such as ultraviolet exposure, season, race,
and dietary intake are all known to effect levels of
25-OHD in humans. A decrease in vitamin D levels
with advancing age has been demonstrated in the
literature. Anticonvulsants have been shown to
cause a decrease in 25-OHD levels. A high
prevalence (30-90 per cent) of sub clinical 25-OHD
deficiency among normal apparently health
populations has been observed in many countries,
particularly in winter months. Studies show high
prevalence of vitamin D deficiency among
Pakistani immigrants in western countries. Vitamin
D deficiency was also reported among pregnant
women in Karachi, Pakistan. Our clinical laboratory
data at AKUH suggests a high prevalence of
vitamin D deficiency in patient population
(unpublished data).

Figure A: Identify red blood cell abnormality.

B

Figure B: Identify white blood cell abnormality.

In Aga Khan Clinical Laboratory, 25-OHD test is
performed by a radioimmunoassay using 125I. The
calibrators are serum based. The assay is FDA
approved because of overall simplicity and its
strong correlation with values obtained from HPLC
analysis. The assay recognizes both plant and
animal vitamin D with equal affinity as well as a
number of other circulating vitamin D metabolites
like 24, 25 dihydroxyvitamin D, 25, 26 dihydroxy
vitamin D, 25-OHD3-26-23-lactone. However, as
these metabolites only account for about 6 per cent
of the overall circulating concentration of vitamin D
and its metabolites, their concentration can be
ignored under this assay format.

C

Figure C: what is your most likely diagnosis
after reviewing bone marrow aspirate?

5

Labrad

January 2007 Volume 32, Issue 1

standardise from laboratory to laboratory, but it is
the most useful in vitro assay for the diagnosis of
vWD.

Ristocetin Cofactor Activity
Dr Safoorah Khalid, Haematology

The test will be shortly available at Clinical
Laboratory, Aga Khan University Hospital.

The functional property of von Willebrand factor
(vWf) that promotes platelet aggregation by the
drug ristocetin is called ristocetin cofactor activity.
Ristocetin induces an activation of vWf such that it
then binds platelets via the platelet glycoprotein
(GP) 1b receptor1. Ristocetin is an antibiotic that
was taken off the market because it caused
thrombocytopenia in individuals with normal vWf.2

References
1. Friedman KD, Rodgers GM. Inherited
coagulation disorders. In: Greer JP, Foerster J,
Leukens JN, Rodgers GM, Paraskevas F,
th
Glader B. Wintrobe's Clinical Hematology 11
Ed. USA; Lippincott Williams and Wilkins 2004:
1619-67
2. Http://www.uptodateonline.com

Ristocetin cofactor activity is adversely affected by
loss of larger molecular weight vWf multimers. The
discrepancy between ristocetin cofactor activity
and vWf antigen that is observed in qualitative
defects characterised by loss of both the
intermediate and high molecular weight multimers
is thought to be on this basis. Ristocetin cofactor
activity is also generally used to follow a von
Willebrand's disease (vWD) patient's response to
1
therapeutic interventions.
In practice, a standard curve for the ristocetin
cofactor test is constructed by adding serial dilutions
of a standard plasma preparation (the source of
vWf) to fresh or formalinized washed platelets and
then adding ristocetin to a final concentration of
approximately 1.2mg/ml (figure 1). The time to
platelet aggregation is measured and graphed
against the concentration of vWf. The standard
plasma used for the initial curve should be related to
the WHO standard. The results are reported as per
cent of factor activity as determined by the
intersection of the test sample slope on the best-fit
line of the standard dilutions (figure 2). 100 per cent
activity equals 100 IU/dl or 1 IU/ml. When using
Chrono-log Cofactor Assay kit, results of less than
40 per cent are considered abnormal and indicative
of vWD. However, the individual laboratory utilising
its particular instrument or reagent combination
should establish a normal range.

Figure 1:
Aggregation of Platelets in Response to Ristocetin

Abnormal tests should be repeated for
confirmation. However, complete diagnosis and
determination of the variant forms of vWD requires
other factors such as family history, bleeding time,
factor VIII Ag and VIII:C activity.
Figure 2:
Measurement of ristocetin cofactor activity of test plasma
(red Line) against standard plasma (green line)

The ristocetin cofactor test has been difficult to
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obstruction. Radiological appearances. Acta
Radiol 2000;41:612-615.

Portal Biliopathy- An Uncommon Cause of
Biliary Obstruction
Dr Zishan Haider, Dr Ishtiaq A Chishti, Radiology

4. Khuroo MS, Yattoo GN, Zargar SA, Javid G,
Dar MY, Khan BA, Boda MI. Biliary
abnormalities associated with extrahepatic
portal venous obstruction. Hepatology 1993;
17:807-813.

Benign bile-duct strictures are usually caused by
bile-duct injury during cholecystectomy. Less
common causes include sclerosing cholangitis,
chronic pancreatitis, congenital abnormalities, and
nonsurgical trauma. Portal hypertension related
bile duct changes represent another group of
uncommon causes of benign stricture, which can
result in biliary obstruction, choledocholithiasis,
and cholangitis.

A

Portal biliopathy is a rare condition that is usually
not diagnosed. It is associated with presence of
varix around the bile duct with concomitant
ischemic damage and structural alterations of bile
duct wall. This produces obstructive phenomena
(Fig 1). There are scarce reports in the literature
about this entity.
In patients with portal hypertension, particularly
with extrahepatic portal vein obstruction, portal
biliopathy producing biliary ductal and gallbladder
wall abnormalities are common. Portal cavernoma
formation, choledochal varices and ischemic injury
of the bile duct have been implicated as causes of
these morphological alterations. While a majority
of the patients are asymptomatic, some present
with a raised alkaline phosphatase level,
abdominal pain, fever and cholangitis.
Choledocholithiasis may develop as a
complication and manifest as obstructive jaundice
with or without cholangitis. The knowledge of portal
biliopathy is very important because it is a less
commonly seen entity in radiology, so accurate
recognition can make prompt diagnosis.

B

References
1. Sumathi B, Randhir J, Sekhar KS, Malathi S,
Reddy DN, Jayanthi V. Portal biliopathy. J
Assoc Physicians India - 2006; 54: 483-4.

Fig 1:
(A) Axial post contrast CT scan of abdomen showing moderate
intrahepatic biliary dilatation without any focal lesion in the liver

2. Chandra R, Kapoor D, Tharakan A, Chaudhary
A, Sarin SK. Portal biliopathy.J Gastroenterol
Hepatol 2001;16:1086-1092.

(B) Same patient in lower section of abdominal CT
showing distal common bile duct is encased by
varices leading to its narrowing and obstruction suggestive
of portal biliopathy

3. Nagi B, Kochhar R, Bhasin D, Singh K.
Cholangiopathy in extrahepatic portal venous

7

Labrad

January 2007 Volume 32, Issue 1

Laboratory Diagnosis of Hepatitis C:
Transition from Serological to
Molecular Methods
Dr Aqsa Nasir, Dr Tariq Moatter,
Molecular Pathology

especially useful when transaminase
concentrations are normal, when other causes of
liver disease are present (alcohol consumption), in
immunosuppressed patients (graft recipients, HIV
co-infected patients), and in acute hepatitis C
before antibodies have developed.

Chronic Hepatitis C (HCV) Virus infection is a
leading cause of cirrhosis, hepatocellular
carcinoma, gastrointestinal tract haemorrhage and
hepatic insufficiency. Evolution of latest antiviral
therapies has reduced the risk of disease
progression but unfortunately, deaths due to HCV
are increasing due to inadequate and therefore late
detection and treatment. However, major
breakthroughs have been achieved in its diagnosis
and treatment. Timely diagnosis and an effective
treatment plan is very important to reduce the high
mortality rate among patients with HCV infection.
Several diagnostic tests are available in this
regard. They are grouped into:

While a single qualitative positive test for HCV RNA
confirms active viral replication, a single negative
assay does not exclude viremia and may reflect
only a viral load below the detection limit of the
assay. Therefore, a follow-up qualitative HCV RNA
is required to exclude active HCV replication. Once
HCV infection is confirmed repeating the test does
not help in managing untreated patients, except for
determining whether an acute infection has
resolved.

!
!

HCV Quantification
It gives the exact quantity of HCV RNA in the given
sample. The HCV RNA level can be quantified by
means of:

Serological Assay for Antibodies;
Molecular Tests for Viral Particles.

!
!

Serological Assays for Antibodies
Diagnosis of the infection is based on detection for
serum antibodies against HCV. The virus has an
incubation period of 2-26 weeks (average 6-7
weeks). Seroconversion occurs at an average of 23 months.

Target Amplification Technique (PCR)
Signal Amplification Technique (Branched DNA
Assay)

Quantification of HCV RNA has no prognostic
value in predicting the severity of HCV-induced
liver injury. Viral load is an independent predictor of
treatment response when assessed before
therapy, and measurement of viral load is useful in
monitoring the efficacy of the treatment. In most
studies, high base line viral load has been defined
as greater than 2x106 HCV RNA copies / ml, but
there is variation in the results of the HCV RNA
quantification used by the different assays. The
role of HCV RNA quantification affects the
treatment plan in the following two ways:

Enzymes immunoassays are very sensitive and
very specific and detect antibodies within 4-10
week of infection. Immunosuppressed patients can
have false negative results, including those with
HIV infection, renal failure, and HCV associated
essential mixed cryoglobulinaemia. Antibodies
against HCV are still detectable during and after
treatment, irrespective of therapeutic response.

!
!

Once seroconversion occurs, these tests usually
remain positive. However, the concentration of
HCV antibodies decreases gradually over time in
few patients in whom infection spontaneously
resolves.

Baseline HCV RNA viral load
The genotype of the HCV

Patients with high baseline viral loads are less
likely to achieve a sustained viral response (SVR)
than those with low viral loads. For example, 7-13
per cent of highly viremic patients in two large trials
achieved SVR after receiving standard interferon
therapy alone for 48 weeks, compared with 29-31
per cent with low baseline viral loads. Patients with
high viral loads responded well (36-40 per cent)
when treated with combination treatment
(interferon plus ribavirin) for 48 weeks as
compared to 24 weeks regimen (27-28 per cent).
However, the results were same in patients with

Molecular Tests for Viral Particles
Qualitative PCR Tests
Qualitative HCV RNA tests are based on PCR
techniques and can detect viral copies as low as
100 copies of HCV RNA per ml of serum (50 IU per
ml). This is the most specific test of infection. It is

8
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low HCV RNA levels at baseline who were treated
for 24 weeks as compared to those who got the
therapy for 48 weeks. Regarding treatment with
peg interferon alpha 2a, patients with pretreatment
low viral load (a baseline HCV RNA level of < 2x106
copies per ml) responded well and were most likely
to be associated with a SVR than those with high
viral load.

and more than 100 subtypes (identified by lower
case letters, for example, 1a and 1b) have been
identified. The HCV genotype and subtype are
intrinsic characteristics and do not change during
the course of the infection. The clinical course,
including long-term complications of chronic HCV,
is genotype independent. There is a consensus on
the fact that the HCV genotypes are predictors to
the antiviral therapy response. HCV has the
following genotypes/subtypes identified by reverse
transcription methods:
1a-1c
2a-2d
3a-3f
4a-4k
5a
6a,
new subtypes are continuously being discovered.

The role of the measurement of HCV RNA levels
for therapy differs in various genotypes. Baseline
viral load is not necessary in patients with genotype
2 or 3. However, in monitoring of patients in
genotype 1 measurement of HCV RNA before
treatment and again after 12 weeks of treatment is
very useful and, according to the present
knowledge, also for those with genotype 4, 5 and 6.
A 2-log drop at least or undetectable HCV RNA at
week12 is defined as early virological response
(EVR) which is now believed to have a poor
positive predictive value but an excellent negative
predictive value to SVR. These results will help in
deciding whether to stop or continue the treatment
as early as 12 weeks after the start of therapy.
However, the clinical reliability of serial HCV viral
load testing in the same patient depends on the use
of the similar quantitative assay each time.
Therefore, treatment could be stopped in patients
with low SVR after 12 weeks of therapy if there is no
extensive fibrosis. By contrast with HIV infection
the viral load does not correlate with the severity of
hepatitis on progression of fibrosis

Clinical Significance of HCV Genotyping
Chronic HCV has historically been a difficult to treat
disease. The primary goal of treatment for HCV is
eradication of HCV. Clinically this is defined as
SVR and is evidenced by undetectable HCV RNA
in serum on sensitive molecular tests performed 24
weeks after completion of treatment. SVR rates
have improved over the past decade as new
treatment strategies have revolutionised the
treatment plan but despite these improvements in
overall SVR rates, less satisfactory results have
been observed in certain patient populations. One
of the most important related factors is HCV
genotypes 1 or 4 and a high HCV RNA level before
treatment.

HCV Serotyping
The advent of serotyping systems has made study
of the clinical significance of the different types of
HCV possible. There are six serotypes of HCV, 1,
2, 3, 4, 5 and 6.

References
1. Gianna Dal Molin, Claudio Tiribelli, Cesare
Campello. A rational use of laboratory tests in
the diagnosis and management of hepatitis C
virus infection. Annals of Hepatology 2003;
2(2):April-june:76-83.
2. Stefan Zeuzem. Heterogeneous virological
response rates to interferon- based therapy in
patients with chronic hepatitis C: who responds
less well ? Ann Intern Med. 2004; 140:370-381.
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Hepatic steatosis in hepatitis C virus genotype
3 infection: does it correlate with body mass
index,fibrosis, and HCV risk factors? Dig Dis
Sci. 2004 Jan; 49(1): 25-9.
4. Caruntu FA, Benea L. Acute hepatitis C virus
infection: diagnosis,pathogenesis , treatment.
J Gastrointestin Liver Dis. 2006 Sep; 15
(3):249-56.

Serological methods are used for the detection of
antibodies directed to genotype specific HCV
epitopes. The assay identifies only the types but
not the sub types of HCV. The concordance with
molecular assays is around 95 per cent and is
higher for genotype1 than for the others. Mixed
serologic reactivity is sometimes observed. This
test cannot distinguish between true mixed
infection and cross reactivity or recovery from one
genotype infection and persistence of viremia with
another.
HCV Genotyping
On the basis of variations in the nucleotide
sequence of HCV, six genotypes (numbered 1 to 6)
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Answer to Quiz
Laboratory Diagnosis of Pernicious Anaemia

B

Dr Naveen Naz Syed, Haematology
Patient History
The patient is a 82 year old male who presented to
the emergency department with complains of
progressive fatigue and shortness of breath on
exertion over a two-to-three month period. He had
no history of drug intake, infections, bleeding or
bruising in the past. However, he had recurrent
episodes of acid peptic ulcer disease. Physical
exam showed pallor with mild scleral icterus, lungs
clear to auscultation, regular heart rate with no
audible murmurs. Abdomen examination revealed,
palpable liver 2 cm below the left costal margin, and
spleen was not enlarged.

Figures A and B: peripheral smear 40 and 100 X objective
showing hyper segmented neutrophils and macrocytes

A number of laboratory investigations were
requested including complete blood count, bone
marrow examination, cytogenetics and various
biochemical tests. The results are as follows:

C

Complete Blood Count
Patient Value Normal Range (Male)
Hemoglobin

2.7 g/dL

12.9-16.9

Hematocrit

7.7%

38.0-48.8

MCV

129.7 fL

82.6-97.4

MCH

34.8 pg

27.8-334

WBC

9

2.6 x 10 /L

3.8-10.6

POLYMORPHS 68%
Figure C: Bone marrow aspirate 100 X objective,
showing megaloblastic erythropoiesis

LYMPHOCYTES 19%
PLATELETS

9

20 x 10 /L

156-369

Other Laboratory Values on Admission
Included the Following:

A

Patient Value Normal Range (Male)
Reticulocytes

9.2%

0.8-2.0

LDH

6338 IU/L

<170

T. Bilirubin

8.8 mg/dL

0.3-1.5

D. Bilirubin

<0.1

B12

<150 pg/mL

211-911

RBC Folate

805 ng/mL

293-809

Intrinsic factor

Positive

Negative

Antibody
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Cytogenetics
Normal, 46 X, Y.

usually shows a macrocytic anemia with a mild
leucopenia and thrombocytopenia. The mean
cell volume (MCV) and mean cell hemoglobin
(MCH) are increased, with a mean corpuscular
hemoglobin concentration (MCHC) within the
reference range. The leucopenia and
thrombocytopenia usually parallel the severity
of the anaemia. The peripheral smear shows
oval macrocytes, hyper segmented
granulocytes, and aniso-poikilocytosis. In
severe anaemia, red blood cell inclusions may
include Howell-Jolly bodies, cabot rings, and
punctate basophilia. The macrocytosis can be
obscured by the coexistence of iron deficiency,
thalassemia minor or inflammatory disease.

Based on the above labs, diagnosis of
megaloblastic anemia secondary to B12 deficiency
was made. As the patient was sero-positive for
intrinsic factor antibodies (IFA), pernicious anemia
was a likely possibility.
Pernicious Anaemia
Pernicious anaemia is a rare disorder
characterised by the inability of the body to
properly utilise vitamin B12 and, results from the
lack of the gastric protein known as intrinsic factor,
without which vitamin B12 cannot be absorbed.
The symptoms of pernicious anaemia may include
weakness, fatigue, palpitation, and/or progressive
neuropathy. Recurring episodes of anaemia
(megaloblastic) and an abnormal yellow coloration
of the skin (jaundice) are also common.

2. Serum B12 Levels: low.
3. A Bone Marrow Aspirate and Biopsy:
Hypercellular and show trilineage
differentiation.
Erythroid precursors are large and often oval;
nucleus is large and contains course mottled
chromatin clumps, providing a checkerboard
appearance. Nucleoli are visible in the more
immature erythroid precursors. An imbalance
in the rate of maturation of the nucleus relative
to the cytoplasm exists, such that disassociation
between the maturity of the nucleus and the
hemoglobinization of the orthochromic
megaloblastic normoblasts occurs.
Giant metamyelocytes and bands are present,
and the mature neutrophils and eosinophils are
hyper segmented.
Imbalanced growth of megakaryocytes is
evidenced by hyperdiploidy of the nucleus and
the presence of giant platelets in the smear.
Lymphocytes and plasma cells are spared from
the cellular gigantism and cytoplasmic
asynchrony observed in other cell lineages.

Pernicious anaemia is thought to be an
autoimmune disorder, and certain people may
have a genetic predisposition to this disorder. The
disease is associated with human leucocyte
antigen (HLA) types A2, A3, and B7 and type A
blood group.
Anti-parietal cell antibodies occur in 90 per cent of
patients with pernicious anaemia but in only 5 per
cent of healthy adults. Similarly, binding and
blocking antibodies to IF are found in most patients
with pernicious anemia. A greater association than
anticipated exists between pernicious anemia and
other autoimmune diseases, which include thyroid
disorders, type I diabetes mellitus, ulcerative
colitis, Addisons disease, infertility, and acquired
agammaglobulinemia. An association between
pernicious anaemia and Helicobacter pylori
infections has been postulated but not clearly
proven.

4. Intrinsic Factor Antibody: Enzyme linked
immunosorbent assay (ELISA) is utilised for
qualitative and semi-quantitative detection of
antibodies to intrinsic factor in patient serum.

Combined system disease: a history of either
paresthesia in the fingers and toes or difficulty with
gait and balance should prompt a careful
neurological examination. Loss of position sense in
the second toe and loss of vibratory sense for a
256-Hz but not a 128-Hz tuning fork are the earliest
signs of postero-lateral column disease. If
untreated, this can progress to spastic ataxia from
demyelination of the dorsal and lateral columns of
the spinal cord.

Treatment:
Treatment in our patient included a blood
transfusion due to the severity of his anaemia, then
therapy with intravenous cyanocobalamin
supplements, resulting in stabilization of his
laboratory values. An important aspect of
treatment for pernicious anaemia is that it will need
to be continued lifelong.

Lab Studies
1. Peripheral Blood: The peripheral blood
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Transmission
These viral illnesses are mosquito borne and by
and large its transmission is dependent upon
mosquito bite. The occurrence of DF outbreaks is
linked to a number of factors such as density of
vector (Aedes aegypti), source (an infected febrile
person) and presence of susceptible hosts in the
community. The Aedes aegypti mosquito is
commonly found in urban dwellings, indoors and
outdoors. Therefore it is easy to speculate that fast
urbanisation and dense population facilitates the
progress of outbreak.

Dengue Fever
Drs Afia Zafar, Erum Khan, Microbiology
Dengue is a mosquito-borne disease that is
caused by Dengue virus which is usually endemic
in tropics. Dengue virus family consists of four
related species (DEN1-DEN4). Infection by one
type confers immunity to that particular type only,
but does not protect against other types. In fact;
second infection by another serotype is more
serious.
Clinical Feature
Dengue virus infection may be asymptomatic or
may lead to dengue fever (DF) or dengue
hemorrhagic fever (DHF) or dengue shock
syndrome (DSS).

Diagnosis
Since clinical features are indistinguishable from
other common diseases, laboratory confirmation of
dengue virus is important from management and
epidemiological point of view. Detection of
antibodies against dengue virus in the blood of the
infected patient is the simplest method of
diagnosis. This test is available at the Aga Khan
University laboratory. However, in some patients
(30 per cent) antibodies may not be detectable
during the acute phase of the disease in such
cases special test like PCR is required to confirm
the diagnosis.

Dengue Fever
The clinical features of DF frequently depend on
the age of the patient. Infants and young children
may have a nonspecific febrile disease, often with
a maculopapular rash. Older children and adults
may have either a mild flu like illness or the classic
incapacitating disease with high fever of abrupt
onset, sometime with two peaks, severe
headache, pain behind the eyes, muscle and bone
or joint pains, nausea, vomiting and rash.
Leucopenia (low white blood cells) and
thrombocytopenia (low platelets) are frequently
associated with it. DF is a self limiting disease and
recovery may be associated with prolonged fatigue
and depression, especially in adults.

Treatment
There is no specific anti-viral drug available for the
treatment of patients with dengue fever. Early
diagnosis and symptomatic care is the mainstay in
the treatment. It is important that patients are kept
well-hydrated. Mild cases managed at home are
encouraged to take excess fluid and bed rest.
Severe cases admitted to hospitals are managed
by intravenous drips and blood /platelet transfusion
if required.

Dengue Haemorrhagic Fever
Typical cases of DHF are characterised by four
major clinical manifestations: high fever,
haemorrhagic manifestations, enlarged liver and
circulatory failure.

Prevention
Personal Protection from Mosquito Bite
Use of mosquito repellent and protective clothing is
an important measure to prevent the viral
transmission from mosquito bite. Windows and
doors should be lined with the thin nets to prevent
entry of mosquitos in the house. Frequent
insecticide use inside the house is encouraged

Dengue Shock Syndrome
The condition of patients who progress to shock
suddenly deteriorates after a fever of 2-7 days
duration. This deterioration occurs at the time of, or
shortly after a fall in temperature between the third
and the seventh day of the disease. There are
typical signs of circulatory failure: the skin
becomes cool, blotchy and congested, the pulse
becomes rapid and patient enters into a critical
stage of shock.

Measures to Prevent Mosquito Breeding
Since there is currently no vaccine available;
prevention is mainly targeted in the eradication of
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mosquito breeding points in the community.
Prevention is only possible if collective effort is
made by all members of the community. Proper
disposal of household waste is first and foremost.
Water in the containers should be stored properly
with covering lids. Water in flower vases and fridge
drains should be changed frequently, at least on
weekly basis.

!

spine and 2 per cent to 3 per cent for the
femoral
region.)
neckneck
region.)
It allows for standardisation of data based on
age, weight, height, and ethnic background.

Aga Khan University Hospital acquired its DEXA
machine (Hologic Discovery) two years back.
Since its inception, it has proved itself in helping
establish osteoporosis in individuals as well as
identifying patients who have a low bone mass and
are in need of specific treatments to help in the
control of further deterioration of their bony mineral
content.

References
Dengue hemorrhagic fever: diagnosis, treatment,
nd
prevention and control. 2 edition. WHO. Geneva.

Bone Densitometry (DEXA Scanning)
in the Diagnosis of Osteoporosis

The examination is done on an outpatient basis.
The technique involved is simple with no special
preparations except the withholding of oral intake
of Calcium supplements for a day. However if a
recent barium examination has been done or a
patient has been injected with a contrast for a CT
scan or radioisotope scan, a wait of 10 to 14 days is
advised before undergoing a DEXA test.

Dr Riffat Hussain, Radiology
Osteoporosis has been called the “silent disease”
since damage occurs over many years without any
evident symptoms until a fracture occurs. A broken
bone, for some women, may be the first warning
sign that osteoporosis has occurred.

The test involves a central DEXA examination,
which measures bone density in the hip and spine
as the patient lies on a padded table. An x-ray
generator is located below the patient and an
imaging device, or detector, is positioned above.

Among the available modalities for the diagnosis of
a low bone mass or osteoporosis bone density
scanning, also called dual-energy x-ray
absorptiometry (DXA or DEXA) or bone
densitometry, is today's established gold standard
for measuring bone mineral density (BMD). It is an
enhanced form of x-ray technology that is used to
measure bone loss. It is generally performed on the
lower spine and hips. DEXA bone density testing
is the most accurate method available for the
diagnosis of osteoporosis and is also considered
an accurate estimator of fracture risk
Bone
mineral density tests help in diagnosing
osteoporosis and are more sensitive than ordinary
x-rays by virtue of detecting bone loss at an earlier
stage.

To assess the spine, the patient's legs are
supported on a padded box to flatten the pelvis and
lower (lumbar) spine. To assess the hip, the
patient's foot is placed in a brace that rotates the
hip inward. In both cases, the detector is slowly
passed over the area, generating images on a
computer monitor.
The test is completed in about 10 minutes and the
results of the test are reported the next day.
Bone density testing is strongly recommended in
the following:
! Post-menopausal females;
! Personal or maternal history of hip fracture or
smoking;
! Tall (over 5 feet 7 inches) or thin (less than 125
pounds) post-menopausal females;
! Patients on medications that are known to
cause bone loss, including corticosteroids such
as Prednisone, various anti-seizure
medications such as Dilantin and certain
barbiturates, or high-dose thyroid replacement
drugs;

The advantages that this technique has to offer are
that:
! It uses minimal amounts of radiation;
! It has a high degree of precision
(reproducibility). In addition, each time a patient
returns for a follow-up scan, the prior analysis
can be used to determine if a change has
occurred;
! It measures both the lumbar spine and femoral
neck (the precision is around 1 per cent for the
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Type 1 (formerly called juvenile or insulindependent) diabetics, liver disease, kidney
disease or a family history of osteoporosis;
Patients with high bone turnover, which shows
up in the form of excessive collagen in urine
samples;
Hyperthyroidism;
Previous history of fracture after mild trauma;
X-ray evidence of vertebral fracture or other
signs of osteoporosis.

Western Blot for HIV 1 Virus
Ms Naureen Niaz Ali and Dr Jawaid Jabbar,
Chemical Pathology
Human immunodeficiency virus (HIV) is a
retrovirus that causes acquired immunodeficiency
syndrome (AIDS). In AIDS, there is failure of
immune system so that the patients are prone to
life-threatening opportunistic infections.
There are 2 types of HIV; 1 and 2. Ninety per cent
of AIDS patients are affected by HIV-1 worldwide,
The basic viral proteins of HIV-1 are: (as shown
diagrammatically in fig. 1 and listed in Table 1 )

Bone Mineral Density Scan of lumbar spine showing osteopenia

Figure 1
Schematic Representation of the Structure of HIV-1

DENOMINATION GENOME NATURE
GP 160
ENV
Glycoprotein precursor of
GP 110/120 and GP 41
GP100/120
ENV
Envelope Glycoprotien
P68
POL
Reverse transcriptase
P55
GAG
Precursor of core protein
P52
POL
Reverse transcriptase
GP41
ENV
Transmembrane Glycoprotein
P40
GAG
Precursor of core protein
P34
POL
Endonuclease
P24/25
GAG
Core protein
P18
GAG
Core protein
Table 1

Diagnostic Approach
Screening
The initial approach is to screen the suspected
individuals for the presence of antibodies to both

Bone Mineral Density Scan of Left Hip showing osteopenia
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HIV-1 and HIV-2. At Aga Khan University Clinical
Laboratory a micro particle enzyme immunoassay
is use to detect antibodies to both HIV-1 and HIV-2.

Eighth Sheffield International
Conference - Diagnostic Imaging
UK based radiologists, Sheffield University
collaborate with AKU for radiology meeting

False positive results may occur due to the
following:
1- Hyperlipimic samples;
2- Hemolysed or plasma samples;
3- Multiparous women;
4- Recent recipients of influenza vaccine;
5- Recent recipients of Hepatitis B vaccines;
6- Patients with autoimmune disease.

Reported by Ms Nida Husain, Radiology
The two-day eighth
Sheffield International
Conference on Diagnostic
Imaging was held at Aga
Khan University on
January 13 and 14, 2007.
This biennial conference
was organised by Sheffield
Diagnostic Imaging, a
group of UK-based
physicians and Sheffield
Mr. Hamish Daniel, Deputy
University UK, and was
High Commissioner, UK
hosted by Aga Khan
University (AKU). 21 invited speakers from the UK,
one from Netherlands and four from Aga Khan
University (AKU) made presentations on various
sub-specialties and findings from latest research.
The conference's inaugural session was attended
by radiology professionals, physicians and
surgeons from all over Pakistan, and was opened
by Mr Hamish Daniel, Deputy High Commissioner,
British High Commission who also inaugurated a
concurrent 'Scientific Poster Exhibition' and a
display of radiology-related equipment.

Confirmatory Testing (Western Blot)
The confirmation for the presence of the virus
requires testing with western blot technique to
identify the basic viral proteins.
The test is based on indirect ELISA technique on a
nitrocellulose strip containing all the HIV1constituent proteins and an internal anti-IgG
control. Firstly, strip is rehydrated and samples are
incubated on the strip along with controls. If antiHIV1 antibodies are present, they bind to the
identified viral proteins present on the strip. After
washing, the alkaline phosphates-labeled antihuman IgG antibodies are incubated. The
conjugate binds to Anti-HIV1 antibodies captured
on the solid phase. After washing, the colour
development solution allows demonstrating the
enzymatic activity of the complexes bound to
nitrocellulose. The appearance of specific
coloured bands allows demonstrating the
presence of anti- HIV1 antibodies in the sample.
Interpretation
1- Positive:
Presence of 2 ENV protein and or GAG and or
POL protein.
2- Indeterminate:
Presence of 1 ENV protein and or GAG and or
POL, Presence of a GAG and POL and only
presence of GAG and POL protein.
3- Negative:
No bands present on the strip.
Indeterminate results may reflect one of the
following alternatives:
a) -Seroconversion
b) -HIV-2
c) -Cross reactivity due to the retrovirus.

Mr. Hamish Daniel and Prof. Sameh Morcos Inaugurating the Scientific Poster
Exhibition with members of the organising committee
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Dr Nadeem Ahmed,
Chairman Department of
R a d i o l o g y, A K U H
welcomed the guests and
recognised the Sheffield
Group's contribution to
promote global education
through such conferences,
and especially thanked the
invited international
Dr Nadeem Ahmad, Chairman,
speakers and participants.
Department of Radiology,
Professor Dr Sameh
at the inaugural session
Morcos, head of Sheffield
Diagnostic Imaging
provided an overview of the conference. The chief
guest Mr Hamish Daniel, stressed upon the
importance of country-to-country linkages in health
care, as well as highlighting the sheer significance
of the human factor not withstanding technological
innovations.

understanding of the
dynamic field of radiology,
presently undergoing very
rapid change with new
technology transforming
this specialty into specific
subspecialties. Available
facilities in Pakistan are fast
increasing and the
organisers saw the
necessity of expanding the
Dr Zafar Sajjad, Associaate
Professor, Chairman Organising pool of appropriatelyCommittee, giving his welcome
educated radiologists. It is
address at the inaugural session
important that not only
radiologists but all health care providers keep
abreast of latest trends and technologies.
The conference is a step towards initiating
collaborative research projects and understanding
at institutional, national and international levels.
Over 400 participants attended the conference
from Pakistan and abroad. The conference was
accredited 11 Category-1 CPD credits by the Royal
College of Radiologists of the United Kingdom.

A unique feature of the Sheffield International
Conference was that it is held in developing
countries, enabling concerned medical
practitioners and technicians in these countries to
familiarise themselves with state-of-the-art
technologies and innovations, and the existing
knowledge base.
Presentations made were
focused on common
diseases in Pakistan with
emphasis on both basic
and advanced imaging
techniques. Topics covered
during the conference
included radiology in
trauma and haemorrhage,
oncology, women imaging,
imaging in diabetes,
vascular imaging,
cardiothoracic imaging,
neuro-radiology, nuclear
imaging, etc.

As a part of its social responsibility and
commitment to the advancement of health
research and continuing education, AKU regularly
holds seminars, symposiums and events to raise
awareness about health and education related
issues which are of national importance and
interest.

Prof. Sameh Morcos, Chairman,
Sheffield Diagnostic Imaging,
addressing the inaugural session

The conference was designed to provide an
opportunity to radiologists, technicians and other
members of Pakistan's medical community to
expand and build upon their knowledge and

Mr Nadeem Mustafa Khan, DG and CEO, AKUH, Captain (R) Habib Khan,
Manager Radiology, Dr Nadeem Ahmad, Chairman Radiology,
Mr Hamish Daniel, Deputy High Commissioner, UK,
Dr Sameh Morcos, Chairman Sheffield Diagnostic Imaging, and
Dr Zafar Sajjad, Associate Professor, Chair Organising Committee
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